Role of progesterone metabolites in mammary cancer

Journal of Dairy Research

Volumn 72, Issue SPEC. ISS., 2005, Pages 51-57

  Wiebe, John P ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

3 dihydroprogesterone; 5 dihydroprogesterone; 5 reductase; Cell adhesion; Cell proliferation; Hydroxysteroid oxidoreductases

Indexed keywords

20ALPHA HYDROXYSTEROID DEHYDROGENASE; 3 ALPHA HYDROXYSTEROID DEHYDROGENASE (B SPECIFIC); 3ALPHA HYDROXYSTEROID DEHYDROGENASE; MESSENGER RNA; PREGNANE DERIVATIVE; PROGESTERONE; STEROID 5ALPHA REDUCTASE;

BREAST TUMOR; CELL ADHESION; CELL DIVISION; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; PATHOLOGY; REVIEW; TUMOR CELL LINE;

20-ALPHA-HYDROXYSTEROID DEHYDROGENASE; 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE (B-SPECIFIC); BREAST NEOPLASMS; CELL ADHESION; CELL DIVISION; CELL LINE, TUMOR; HUMANS; PREGNANES; PREGNENES; PROGESTERONE; RNA, MESSENGER; TESTOSTERONE 5-ALPHA-REDUCTASE;

ANIMALIA; CANIS FAMILIARIS;

EID: 24944469767     PISSN: 00220299     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0022029905001214     Document Type: Review

References (46)

1. Anderson TJ, Battersby S, King RJB, McPherson K & Going JJ 1989 Oral contraceptive use influences resting breast proliferation. Human Pathology 20 1139-1144
2. Beck CA, Wolfe M, Murphy LD & Wiebe JP 1997 Acute, nongenomic actions of the neuroactive gonadal steroid, 3α-hydroxy-4-pregnen-20-one (3αHP), on FSH release in perifused rat anterior pituitary cells. Endocrine 6 221-229
3. Braunsberg H, Coldham NG, Leake RE, Cowan SK & Wong WR 1987 Action of a progesterone on human breast cancer cells: mechanism of growth stimulation and inhibition. European Journal of Cancer & Clinical Oncology 23 563-572
4. Cappelletti V, Miodini P, Fiovaranti L & Di Fronzo G 1995 Effect of progestin treatment on estradiol- and growth factor-stimulated breast cancer cell lines. Anticancer Research 15 2551-2556
5. Cialacu V, Zhang G & Wiebe JP 2003 Induced detachment of MCF-7 breast cancer cells by the progesterone metabolite, 5α-pregnane-3,20-dione, is linked to activation of the mitogen-activated protein kinase (Erk/MAPK) pathway. Endocrine Society Annual Meeting Abstracts 85 P1, 138, p 166
6. Clark CL & Sutherland RL 1990 Progestin regulation of cellular proliferation. Endocrine Reviews 11 266-302
7. Clark R, Skaar T, Baumann K, Leonessa F, James M, Lippman A, Thompson EW, Freter C & Brunner N 1994 Hormonal carcinogenesis in breast cancer: cellular and molecular studies of malignant progression. Breast Cancer Research & Treatment 31 237-248
8. Cohen SM & Ellwein LB 1990 Cell proliferation in carcinogenesis. Science 249 1007-1011
9. Concannon PW, Spraker TR, Casey HW & Hansel W 1981 Gross and histopathological effects of medroxyprogesterone acetate and progesterone on the mammary glands of adult beagle bitches. Fertility & Sterility 36 373-387
10. Dhanvantari S & Wiebe JP 1994 Suppression of follicle-stimulating hormone by the gonadal- and neurosteroids 3α-hydroxy-4-pregnen-20-one involves actions at the level of the gonadotrope membrane/ calcium channel. Endocrinology 134 371-376
11. Glasier MA, Wiebe JP & Hobkirk R 1994 Progesterone metabolism by guinea pig intrauterine tissues. Journal of Steroid Biochemistry & Molecular Biology 51 199-207
12. Going JJ, Anderson TJ, Battersby S & MacIntyre CCA 1988 Proliferative and secretory activity in human breast during natural and artificial menstrual cycles. American Journal of Pathology 130 193-204
13. Kip1. Molecular Endocrinology 11 1593-1607
14. Hamilton JM 1974 Comparative aspects of mammary tumors. In Advances in Cancer Research, pp. 1-45. (Eds G Klein, S Weinhouse & A Haddow). New York: Academic Press
15. Horwitz KB, Wei LL, Sedlacek SM & D'Arville CN 1985 Progestin action and progesterone receptor structure in human breast cancer: a review. Recent Progress in Hormone Research 41 249-316
16. Ismail PM, Amato P, Soyal SM, DeMayo FJ, Conneely OM, O'Malley BW & Lydon JP 2003 Progesterone involvement in breast development and tumorigenesis - as revealed by progesterone receptor "knockout" and "knockin" mouse models. Steroids 68:779-787.
17. Jabara AG 1967 Effects of progesterone on 9,10-dimethyl-1,2- benzanthracene-induced mammary tumours in Sprague-Dawley rats. British Journal of Cancer 21 418-429
18. Kessler M & von Bomhard D 1997 [Small animal contribution to pediatric oncology. In German]. Berliner Tierarztliche Wochenschrift 110 311-314
19. King RJB 1991 A discussion of the role of estrogen and progestin in human mammary carcinogenesis. Journal of Steroid Biochemistry & Molecular Biology 39 811-818
20. Lanari C & Molinolo AA 2002 Progesterone receptors-animal models and cell signaling in breast cancer. Diverse activation pathways for the progesterone receptor: possible implications for breast biology and cancer. Breast Cancer Research 4 240-243
21. Lewis MJ, Wiebe JP & Heathcote JG 2004 Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma. BMC Cancer 4 27 (pp 1-12) (http://www.biomedcentral. com/1471-2407/4/27)
22. Luo S, Stojanovic M & Labrie F 1997 Inhibitory effect of the novel anti-estrogen EM-800 and medroxyprogesterone acetate on estrone-stimulated growth of dimethylbenz[a]anthracene-induced mammary carcinoma in rats. International Journal of Cancer 73 580-586
23. Lydon JP Sivaraman L & Conneely OM 2000 A reappraisal of progesterone action in the mammary gland. Journal of Mammary Gland Biology & Neoplasia 5 325-338
24. Mol JA, van Garderen E, Rutteman GR & Rijnberk A 1996 New insights in the molecular mechanism of progestin-induced proliferation of mammary epithelium: induction of the local biosynthesis of growth hormone (GH) in the mammary gland of dogs, cats and humans. Journal of Steroid Biochemistry & Molecular Biology 57 67-71
25. Musgrove AE & Sutherland RL 1994 Cell cycle control by steroid hormones. Seminars in Cancer Biology 5 381-389
26. Owen LN 1979 A comparative study of canine and human breast cancer. Investigative and Cell Pathology 2 257-275
27. Pawlak KJ & Wiebe JP 2003 Plasma membrane receptors for the cancer-promoting progesterone metabolite, 5α-pregnane-3,20-dione, are modulated by other endogenous steroid hormones. Endocrine Society Annual Meeting Abstracts 85 P1, 136, p166
28. Pearson G, Robinson F, Beers GT, Xu B, Karandikar M, Beerman K & Cobb MH 2001 Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocrine Reviews 22 153-183
29. Pike MC, Spicer DV, Dahmoush L & Press MF 1993 Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiologic Reviews 15 17-35
30. Raz A 1988 Adhesive properties of metastasizing tumor cells. Ciba Foundation Symposium 141 109-122
31. Russo J, Russo IH, Rogers AE, van Zwieten MJ & Gusterson B 1990 Pathology of tumors in laboratory animals. Tumors of the rat. Tumors of the mammary gland. IARC Scientific Publications 99 47-78
32. Santen RJ, Manni A, Harvey H & Redmond C 1990 Endocrine treatment of breast cancer in women. Endocrine Reviews 11 221-265
33. Santen RJ, Sing RX, McPherson R, Kumar R, Adam L, Jeng M-H & Yue W 2002 The role of mitogen-activated protein (MAP) kinase in breast cancer. Journal of Steroid Biochemistry & Molecular Biology 80 239-256
34. Segaloff A 1975 Steroids and carcinogenesis. Journal of Steroid Biochemistry 6 171-175
35. Sukumar S, McKenzie K & Chen Y 1995 Animal models for breast cancer. Mutation Research 333 37-44
36. Webster MA & Muller WJ 1994 Mammary tumorigenesis and metastasis in transgenic mice. Seminars in Cancer Biology 5 69-76
37. Weiler PJ & Wiebe JP 2000 Plasma membrane receptors for the cancer-regulating progesterone metabolites, 5α-pregnane-3,20-dione and 3α-hydroxy-4-pregnen-20-one in MCF-7 breast cancer cells. Biochemical and Biophysical Research Communications 272 731-737
38. Welsh CW 1982 Hormones and murine mammary tumorigenesis: an historical view. In: Hormonal Regulation of Mammary Tumors, pp. 1-29 (Ed. BS Leung). Montreal, Canada: Eden Press
39. Wiebe JP 1997 Nongenomic actions of steroids on gonadotropin release. Recent Progress in Hormone Research 52 71-101
40. Wiebe JP & Muzia D 2001 The endogenous progesterone metabolite, 5α-pregnene-3,20-dione, decreases cell-substrate attachment, adhesion plaques, vinculin expression, and polymerized F-actin in MCF-7 breast cancer cells. Endocrine 16 7-14
41. Wiebe JP & Lewis MJ 2003 Activity and expression of progesterone metabolizing 5α-reductase, 20α-hydroxysteroid oxidoreductase and 3α(β)-hydroxysteroid oxidoreductases in tumorigenic (MCF-7, MDA-MB-231, T-47D) and nontumorigenic (MCF-10A) human breast cancer cells. BMC Cancer 3 (pp. 1-15) (http://www.biomedcentral.com/1471-2407/3/9)
42. Wiebe JP, Myers KI & Auersperg N 1987 Modification of steroidogenesis in rat adrenocortical cells transformed by Kirsten Murine Sarcoma virus. Cancer Research 47 1325-1332
43. Wiebe JP, Boushy D & Wolfe M 1997 Synthesis, metabolism and levels of the neuroactive steroid, 3α-hydroxy-4-pregnen-20-one (3αHP), in rat pituitaries. Brain Research 764 158-166
44. Wiebe JP, Barr KJ & Buckingham KD 1991 A radioimmunoassay for the regulatory steroid, 3α-hydroxy-4-pregnen-20-one (3αHP). Journal of Steroid Biochemistry & Molecular Biology 38 505-512
45. Wiebe JP, Dhanvantari S, Watson PH & Huang Y 1994 Suppression in gonadotropes of gonadotropin-releasing hormone-stimulated follicle-stimulating hormone release by the gonadal- and neurosteroid 3α-hydroxy-4-pregnen-20- one involves cytosolic calcium. Endocrinology 134 377-382
46. Wiebe JP, Muzia D, Hu J, Szwajcer D, Hill SA & Seachrist JL 2000 The 4-pregnene and 5α-pregnane progesterone metabolites formed in non-tumorous and tumorous breast tissue have opposite effects on breast cell proliferation and adhesion. Cancer Research 60 936-943